Meiya Announcement: The company is still undergoing litigation and arbitration arising from the sale of its subsidiary Qinghai Zhongyou Health Huijia Pharmaceutical Chain Co., Ltd. Among them, a mediation agreement has been reached regarding the equity transfer dispute between the company and Jilin Zhiyu Technology Co., Ltd., adjusting the equity transfer payment from 30 million yuan to 20 million yuan, which must be paid by June 10, 2025. In addition, the loan arbitration between the company and Qinghai Huijia is still negotiating the repayment plan, and the company will disclose progress in a timely manner. Currently, it is impossible to determine the impact of the above cases on the company's profits for this period or future periods